Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Operations (2017 - 2025)

Historic Cash from Operations for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.2 million.

  • Catheter Precision's Cash from Operations rose 2055.64% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 1683.94%. This contributed to the annual value of -$9.3 million for FY2024, which is 5489.6% up from last year.
  • Catheter Precision's Cash from Operations amounted to -$2.2 million in Q3 2025, which was up 2055.64% from -$2.3 million recorded in Q2 2025.
  • Catheter Precision's Cash from Operations' 5-year high stood at -$1.7 million during Q2 2024, with a 5-year trough of -$12.1 million in Q1 2023.
  • Its 5-year average for Cash from Operations is -$4.6 million, with a median of -$3.1 million in 2022.
  • The largest annual percentage gain for Catheter Precision's Cash from Operations in the last 5 years was 8388.78% (2024), contrasted with its biggest fall of 5314.98% (2024).
  • Quarter analysis of 5 years shows Catheter Precision's Cash from Operations stood at -$5.7 million in 2021, then skyrocketed by 46.47% to -$3.1 million in 2022, then surged by 38.21% to -$1.9 million in 2023, then plummeted by 53.15% to -$2.9 million in 2024, then increased by 23.99% to -$2.2 million in 2025.
  • Its Cash from Operations stands at -$2.2 million for Q3 2025, versus -$2.3 million for Q2 2025 and -$2.3 million for Q1 2025.